ID   SLR20.A2
AC   CVCL_UY80
DR   cancercelllines; CVCL_UY80
DR   Wikidata; Q98132689
RX   PubMed=19690146;
CC   Problematic cell line: Contaminated. Parent cell line (SLR20) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; 5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: HGNC; 4931; HLA-A (allele A*02:01).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V606 ! SLR20
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 9
//
RX   PubMed=19690146; DOI=10.1158/0008-5472.CAN-08-4511;
RA   Kawabe M., Mandic M., Taylor J.L., Vasquez C.A., Wesa A.K.,
RA   Neckers L.M., Storkus W.J.;
RT   "Heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-
RT   demethoxygeldanamycin enhances EphA2+ tumor cell recognition by
RT   specific CD8+ T cells.";
RL   Cancer Res. 69:6995-7003(2009).
//